On March 28, 2026, a one-day scientific conference on the prevention of haemoglobinopathies took place at the Amphitheatre “Phaedon Fessas” of Laiko General Hospital of Athens. The event was organised by the Unit of Mediterranean Anaemia and the Center of Expertise in Haemoglobinopathies, in collaboration with the hospital’s Nursing Service.
The conference brought together healthcare professionals, researchers, and experts to discuss the latest developments in the prevention, diagnosis, and management of haemoglobinopathies, including thalassaemia and sickle cell disease. Topics ranged from screening strategies and genetic counselling to emerging diagnostic approaches and multidisciplinary collaboration.
Highlighting European collaboration: HELIOS Action
A key moment of the event was the presentation of the HELIOS CA22119 Action during the session on European initiatives.
Dr. Eleni Katsantoni, Dissemination and Outreach Leader of Working Group 5 (WG5), represented HELIOS and introduced the Action’s mission, ongoing activities, and its role in strengthening collaboration across Europe in the field of hemoglobinopathies.
Her presentation emphasised the following:
- The importance of networking between clinicians, researchers, and stakeholders
- The role of HELIOS in knowledge sharing and capacity building
- The Action’s contribution to improving prevention strategies and patient outcomes across Europe
According to the official programme, the HELIOS Action was presented as part of the conference’s focus on European-level initiatives and collaboration.
Strengthening awareness and impact
Participation in events such as this conference is essential for HELIOS, as it:
- Expands the visibility of the action.
- Builds connections with national and international experts
- Promotes best practices in prevention and care
The strong engagement of participants highlighted the continued importance of prevention programmes, especially in regions with a high prevalence of hemoglobinopathies.
Looking ahead
HELIOS remains committed to fostering collaboration, supporting innovation, and promoting awareness in the field of hemoglobinopathies across Europe.